Alpha-ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia [KL974_shOGDH]
RNA-seq (gene expression) · mouse · 14 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 14 samples: 7 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE282977_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1191400 and SRA study SRP547942. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 4 samples read as cases, 2 as controls.
How we read this: 7 replicated groups read from 14 sample titles; they account for 14 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8653869 Murine AML, control shRNA, D0, rep1 Murine AML, control shR…
- GSM8653870 Murine AML, control shRNA, D2, uninduced sorted, rep1 Murine AML, control shR…
- GSM8653871 Murine AML, control shRNA, D2, induced sorted, rep1 Murine AML, control shR…
- GSM8653872 Murine AML, control shRNA, D4, uninduced sorted, rep1 Murine AML, control shR…
- GSM8653873 Murine AML, control shRNA, D4, induced sorted, rep1 Murine AML, control shR…
- GSM8653874 Murine AML, control shRNA, D0, rep2 Murine AML, control shR…
- GSM8653875 Murine AML, control shRNA, D2, uninduced sorted, rep2 Murine AML, control shR…
- GSM8653876 Murine AML, control shRNA, D2, induced sorted, rep2 Murine AML, control shR…
- GSM8653877 Murine AML, control shRNA, D4, induced sorted, rep2 Murine AML, control shR…
- GSM8653878 Murine AML, control shRNA, D4, uninduced sorted, rep2 Murine AML, control shR…
- GSM8653879 Murine AML, OGDH shRNA1, D4, induced sorted, rep1 Murine AML, OGDH shRNA1…
- GSM8653880 Murine AML, OGDH shRNA1, D4, induced sorted, rep2 Murine AML, OGDH shRNA1…
- GSM8653881 Murine AML, OGDH shRNA2, D4, induced sorted, rep1 Murine AML, OGDH shRNA2…
- GSM8653882 Murine AML, OGDH shRNA2, D4, induced sorted, rep2 Murine AML, OGDH shRNA2…
- GSE282980 Alpha-ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia [RN2_shOGDH] 24 samples shares alpha-ketoglutarate, dehydrogenase, vulnerability, therapeutic, leukemia, myeloid, shogdh
- GSE303625 MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia [RNA-Seq] 14 samples shares vulnerability, therapeutic, leukemia
- GSE223323 Enterocyte like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability 148 samples shares vulnerability, therapeutic
- GSE270929 Enterocyte like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability 38 samples shares vulnerability, therapeutic
- GSE271738 Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [ASPN_MyCCaP_10111-AH] 9 samples shares vulnerability, therapeutic
- GSE271740 Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [NRG1_MyCCaP_10722-AH] 9 samples shares vulnerability, therapeutic
- GSE319980 Glucose Transport Dependency Defines a Therapeutic Vulnerability in Myeloproliferative Neoplasms 8 samples shares vulnerability, therapeutic
- GSE271412 MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer 8 samples shares vulnerability, therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.